Search results
21 lip 2024 · Plant-derived exosomes (PDEs) are natural extracellular vesicles (EVs) that are potent to provide organic precision nanomedicine to cancer therapeutics including targeted drug delivery. PDEs are gaining attention due to their safety and efficacy.
Due to their biocompatibility, low toxicity, and ability to traverse biological barriers, plant-derived exosomes present a promising alternative to synthetic nanoparticles for drug delivery, especially in cancer and microbial infection therapy.
1 kwi 2023 · Based on the current literature, PDVs exhibit promising capabilities for cancer therapy in two ways: (1) to express their innate anti-cancer activities as natural bioactive phytomedicine, or (2) to deliver active agents to targeted tumors as drug delivery vesicles.
28 sie 2024 · The potential uses of plant-derived EVs are extensive, ranging from their natural form in delivering supplements and micronutrients to serving as supportive therapies for various conditions, including cancer, inflammatory diseases, and skin disorders.
28 lut 2024 · This review aims to comprehensively analyze the current state of research on plant-derived exosomes as a promising avenue for drug delivery, highlighting anticancer activity, challenges, and future orientation in effective cancer therapeutic development.
29 kwi 2024 · Plant-exosome-like nanovesicles (PELNVs) can provide solutions for many of these challenges because they are innocuous and nonimmunogenic when delivering nanomedicines. Hence, this review will describe the potential use of PELNVs to deliver cancer vaccines.
4 lip 2024 · As the field progresses, modified plant-derived exosomes have the potential to revolutionize cancer therapy, offering targeted, efficient and less toxic treatment options, thus embodying the principles of precision medicine.
